TIDMGSK

RNS Number : 9488U

GlaxoSmithKline PLC

17 July 2018

GlaxoSmithKline plc (the 'Company')

Transaction notification

 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ======================================================================= 
 a)   Name                     Ms E Walmsley 
===  ========================  ============================================= 
 b)   Position/status          Chief Executive Officer 
===  ========================  ============================================= 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================= 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ======================================================================= 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================= 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================= 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ======================================================================= 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ============================================= 
 b)   Nature of the            Acquisition of Ordinary Shares following 
       transaction              the re-investment of dividends paid to 
                                shareholders on 12 July 2018 on Ordinary 
                                Shares held in the Company's Deferred Annual 
                                Bonus Plan. 
===  ========================  ============================================= 
 c)   Price(s) and               Price(s)     Volume(s) 
       volume(s)                              ---------- 
                                  GBP15.766    189 
                                              ---------- 
                                  GBP15.766    206 
                                              ---------- 
                                  GBP15.766    721 
                                              ---------- 
                                  GBP15.766    189 
                                              ---------- 
                                  GBP15.766    206 
                                              ---------- 
===  ========================  ============================================= 
 d)   Aggregated information 
       Aggregated volume 
       Price 
                                 1511 
                                 GBP15.766 
===  ========================  ============================================= 
 e)   Date of the transaction  2018-07-12 
===  ========================  ============================================= 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ============================================= 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ======================================================================= 
 a)   Name                     Mr R G Connor 
===  ========================  ============================================= 
 b)   Position/status          President, Global Manufacturing & Supply 
===  ========================  ============================================= 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================= 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ======================================================================= 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================= 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================= 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ======================================================================= 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ============================================= 
 b)   Nature of the            Acquisition of Ordinary Shares following 
       transaction              the re-investment of dividends paid to 
                                shareholders on 12 July 2018 on Ordinary 
                                Shares held in the Company's Deferred Annual 
                                Bonus Plan. 
===  ========================  ============================================= 
 c)   Price(s) and               Price(s)     Volume(s) 
       volume(s)                              ---------- 
                                  GBP15.766    128 
                                              ---------- 
                                  GBP15.766    107 
                                              ---------- 
                                  GBP15.766    152 
                                              ---------- 
                                  GBP15.766    107 
                                              ---------- 
===  ========================  ============================================= 
 d)   Aggregated information 
       Aggregated volume 
       Price 
                                 494 
                                 GBP15.766 
===  ========================  ============================================= 
 e)   Date of the transaction  2018-07-12 
===  ========================  ============================================= 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ============================================= 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ======================================================================= 
 a)   Name                     Mr L Debruyne 
===  ========================  ============================================= 
 b)   Position/status          President, Global Vaccines 
===  ========================  ============================================= 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================= 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ======================================================================= 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================= 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================= 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ======================================================================= 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ============================================= 
 b)   Nature of the            Acquisition of Ordinary Shares following 
       transaction              the re-investment of dividends paid to 
                                shareholders on 12 July 2018 on Ordinary 
                                Shares held in the Company's Deferred Annual 
                                Bonus Plan. 
===  ========================  ============================================= 
 c)   Price(s) and               Price(s)     Volume(s) 
       volume(s)                              ---------- 
                                  GBP15.766    180 
                                              ---------- 
                                  GBP15.766    228 
                                              ---------- 
                                  GBP15.766    180 
                                              ---------- 
===  ========================  ============================================= 
 d)   Aggregated information 
       Aggregated volume 
       Price 
                                 588 
                                 GBP15.766 
===  ========================  ============================================= 
 e)   Date of the transaction  2018-07-12 
===  ========================  ============================================= 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ============================================= 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ======================================================================= 
 a)   Name                     Mr S Dingemans 
===  ========================  ============================================= 
 b)   Position/status          Chief Financial Officer 
===  ========================  ============================================= 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================= 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ======================================================================= 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================= 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================= 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ======================================================================= 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ============================================= 
 b)   Nature of the            Acquisition of Ordinary Shares following 
       transaction              the re-investment of dividends paid to 
                                shareholders on 12 July 2018 on Ordinary 
                                Shares held in the Company's Deferred Annual 
                                Bonus Plan. 
===  ========================  ============================================= 
 c)   Price(s) and               Price(s)     Volume(s) 
       volume(s)                              ---------- 
                                  GBP15.766    249 
                                              ---------- 
                                  GBP15.766    187 
                                              ---------- 
                                  GBP15.766    510 
                                              ---------- 
                                  GBP15.766    249 
                                              ---------- 
                                  GBP15.766    187 
                                              ---------- 
===  ========================  ============================================= 
 d)   Aggregated information 
       Aggregated volume 
       Price 
                                 1382 
                                 GBP15.766 
===  ========================  ============================================= 
 e)   Date of the transaction  2018-07-12 
===  ========================  ============================================= 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ============================================= 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ======================================================================= 
 a)   Name                     Mr N Hirons 
===  ========================  ============================================= 
 b)   Position/status          SVP, Global Ethics & Compliance 
===  ========================  ============================================= 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================= 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ======================================================================= 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================= 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================= 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ======================================================================= 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ============================================= 
 b)   Nature of the            Acquisition of Ordinary Shares following 
       transaction              the re-investment of dividends paid to 
                                shareholders on 12 July 2018 on Ordinary 
                                Shares held in the Company's Deferred Annual 
                                Bonus Plan. 
===  ========================  ============================================= 
 c)   Price(s) and               Price(s)     Volume(s) 
       volume(s)                              ---------- 
                                  GBP15.766    92 
                                              ---------- 
                                  GBP15.766    67 
                                              ---------- 
                                  GBP15.766    80 
                                              ---------- 
                                  GBP15.766    92 
                                              ---------- 
                                  GBP15.766    67 
                                              ---------- 
===  ========================  ============================================= 
 d)   Aggregated information 
       Aggregated volume 
       Price 
                                 398 
                                 GBP15.766 
===  ========================  ============================================= 
 e)   Date of the transaction  2018-07-12 
===  ========================  ============================================= 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ============================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
      ========================================================================== 
 a)    Name                      Mr B McNamara 
====  =========================  =============================================== 
 b)    Position/status           CEO, GSK Consumer Healthcare 
====  =========================  =============================================== 
 c)    Initial notification/     Initial notification 
        amendment 
====  =========================  =============================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================== 
 a)    Name                      GlaxoSmithKline plc 
====  =========================  =============================================== 
 b)    LEI                       5493000HZTVUYLO1D793 
====  =========================  =============================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================== 
 a)    Description of             American Depositary Shares ('ADSs') 
        the financial              ISIN: US37733W1053 
        instrument 
====  =========================  =============================================== 
 b)    Nature of the             Acquisition of ADSs following the re-investment 
        transaction               of dividends paid to shareholders on 12 
                                  July 2018 on ADSs held in the Company's 
                                  Deferred Annual Bonus Plan. 
====  =========================  =============================================== 
 c)    Price(s) and                Price(s)   Volume(s) 
        volume(s)                             ---------- 
                                    $41.75     78 
                                              ---------- 
                                    $41.75     76 
                                              ---------- 
====  =========================  =============================================== 
 d)    Aggregated information 
   Aggregated volume 
    Price 
 
                                  154 
                                   $41.75 
 ==============================  =============================================== 
 e)    Date of the transaction   2018-07-12 
====  =========================  =============================================== 
 f)    Place of the              New York Stock Exchange (XNYS) 
        transaction 
====  =========================  =============================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ======================================================================= 
 a)   Name                     Mr L Miels 
===  ========================  ============================================= 
 b)   Position/status          President, Global Pharmaceuticals 
===  ========================  ============================================= 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================= 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ======================================================================= 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================= 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================= 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ======================================================================= 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ============================================= 
 b)   Nature of the            Acquisition of Ordinary Shares following 
       transaction              the re-investment of dividends paid to 
                                shareholders on 12 July 2018 on Ordinary 
                                Shares held in the Company's Deferred Annual 
                                Bonus Plan. 
===  ========================  ============================================= 
 c)   Price(s) and               Price(s)     Volume(s) 
       volume(s)                              ---------- 
                                  GBP15.766    145 
                                              ---------- 
===  ========================  ============================================= 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  ============================================= 
 e)   Date of the transaction  2018-07-12 
===  ========================  ============================================= 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ============================================= 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ======================================================================= 
 a)   Name                     Mr D S Redfern 
===  ========================  ============================================= 
 b)   Position/status          Chief Strategy Officer 
===  ========================  ============================================= 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================= 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ======================================================================= 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================= 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================= 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ======================================================================= 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ============================================= 
 b)   Nature of the            Acquisition of Ordinary Shares following 
       transaction              the re-investment of dividends paid to 
                                shareholders on 12 July 2018 on Ordinary 
                                Shares held in the Company's Deferred Annual 
                                Bonus Plan. 
===  ========================  ============================================= 
 c)   Price(s) and               Price(s)     Volume(s) 
       volume(s)                              ---------- 
                                  GBP15.766    117 
                                              ---------- 
                                  GBP15.766    85 
                                              ---------- 
                                  GBP15.766    148 
                                              ---------- 
                                  GBP15.766    117 
                                              ---------- 
                                  GBP15.766    85 
                                              ---------- 
===  ========================  ============================================= 
 d)   Aggregated information 
       Aggregated volume 
       Price 
                                 552 
                                 GBP15.766 
===  ========================  ============================================= 
 e)   Date of the transaction  2018-07-12 
===  ========================  ============================================= 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ============================================= 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ========================================================================= 
 a)   Name                     Ms K Terrell 
===  ========================  =============================================== 
 b)   Position/status          Chief Digital & Technology Officer 
===  ========================  =============================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =============================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ========================================================================= 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =============================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =============================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================================= 
 a)   Description of            American Depositary Shares ('ADSs') 
       the financial             ISIN: US37733W1053 
       instrument 
===  ========================  =============================================== 
 b)   Nature of the            Acquisition of ADSs following the re-investment 
       transaction              of dividends paid to shareholders on 12 
                                July 2018 on ADSs held in the Company's 
                                Deferred Annual Bonus Plan. 
===  ========================  =============================================== 
 c)   Price(s) and               Price(s)   Volume(s) 
       volume(s)                            ---------- 
                                  $41.75     25 
                                            ---------- 
===  ========================  =============================================== 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  =============================================== 
 e)   Date of the transaction  2018-07-12 
===  ========================  =============================================== 
 f)   Place of the             New York Stock Exchange (XNYS) 
       transaction 
===  ========================  =============================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ======================================================================= 
 a)   Name                     Ms C Thomas 
===  ========================  ============================================= 
 b)   Position/status          SVP, Human Resources 
===  ========================  ============================================= 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================= 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ======================================================================= 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================= 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================= 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ======================================================================= 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ============================================= 
 b)   Nature of the            Acquisition of Ordinary Shares following 
       transaction              the re-investment of dividends paid to 
                                shareholders on 12 July 2018 on Ordinary 
                                Shares held in the Company's Deferred Annual 
                                Bonus Plan. 
===  ========================  ============================================= 
 c)   Price(s) and               Price(s)     Volume(s) 
       volume(s)                              ---------- 
                                  GBP15.766    172 
                                              ---------- 
                                  GBP15.766    128 
                                              ---------- 
                                  GBP15.766    161 
                                              ---------- 
                                  GBP15.766    172 
                                              ---------- 
                                  GBP15.766    128 
                                              ---------- 
===  ========================  ============================================= 
 d)   Aggregated information 
       Aggregated volume 
       Price 
                                 761 
                                 GBP15.766 
===  ========================  ============================================= 
 e)   Date of the transaction  2018-07-12 
===  ========================  ============================================= 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ============================================= 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ======================================================================= 
 a)   Name                     Mr P C Thomson 
===  ========================  ============================================= 
 b)   Position/status          President, Global Affairs 
===  ========================  ============================================= 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================= 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ======================================================================= 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================= 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================= 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ======================================================================= 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ============================================= 
 b)   Nature of the            Acquisition of Ordinary Shares following 
       transaction              the re-investment of dividends paid to 
                                shareholders on 12 July 2018 on Ordinary 
                                Shares held in the Company's Deferred Annual 
                                Bonus Plan. 
===  ========================  ============================================= 
 c)   Price(s) and               Price(s)     Volume(s) 
       volume(s)                              ---------- 
                                  GBP15.766    105 
                                              ---------- 
                                  GBP15.766    80 
                                              ---------- 
                                  GBP15.766    100 
                                              ---------- 
===  ========================  ============================================= 
 d)   Aggregated information 
       Aggregated volume 
       Price 
                                 285 
                                 GBP15.766 
===  ========================  ============================================= 
 e)   Date of the transaction  2018-07-12 
===  ========================  ============================================= 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ============================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
      ========================================================================== 
 a)    Name                      Mr D E Troy 
====  =========================  =============================================== 
 b)    Position/status           SVP & General Counsel 
====  =========================  =============================================== 
 c)    Initial notification/     Initial notification 
        amendment 
====  =========================  =============================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================== 
 a)    Name                      GlaxoSmithKline plc 
====  =========================  =============================================== 
 b)    LEI                       5493000HZTVUYLO1D793 
====  =========================  =============================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================== 
 a)    Description of             American Depositary Shares ('ADSs') 
        the financial              ISIN: US37733W1053 
        instrument 
====  =========================  =============================================== 
 b)    Nature of the             Acquisition of ADSs following the re-investment 
        transaction               of dividends paid to shareholders on 12 
                                  July 2018 on ADSs held in the Company's 
                                  Deferred Annual Bonus Plan. 
====  =========================  =============================================== 
 c)    Price(s) and                Price(s)   Volume(s) 
        volume(s)                             ---------- 
                                    $41.75     100 
                                              ---------- 
                                    $41.75     82 
                                              ---------- 
                                    $41.75     89 
                                              ---------- 
                                    $41.75     100 
                                              ---------- 
                                    $41.75     82 
                                              ---------- 
====  =========================  =============================================== 
 d)    Aggregated information 
   Aggregated volume 
    Price 
 
 
                                  453 
                                   $41.75 
 ==============================  =============================================== 
 e)    Date of the transaction   2018-07-12 
====  =========================  =============================================== 
 f)    Place of the              New York Stock Exchange (XNYS) 
        transaction 
====  =========================  =============================================== 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHQDLFFVDFZBBL

(END) Dow Jones Newswires

July 17, 2018 12:46 ET (16:46 GMT)

Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024 Haga Click aquí para más Gráficas Gsk.
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024 Haga Click aquí para más Gráficas Gsk.